Table 2.
Technical aspects of included studies.
| Author | Year | Scanner modality(PET/CT) | Ligand dose | Image analysis | 18F-FDG-PET/CT | ||||
|---|---|---|---|---|---|---|---|---|---|
| Total | TP | FP | FN | TN | |||||
| Bjerring et al. | 2020 | GE Medical Systems, Milwaukee, Wisconsin USA | 4.0 MBQ/kg | Quantitative | 39 | 17 | 9 | 5 | 8 |
| El-Kholy et al. | 2019 | GE, PET/CT Discovery | NA | Quantitative | 34 | 21 | 1 | 3 | 9 |
| Rayamajhi et al. | 2017 | Discovery ST, STE, or RX, GE Healthcare | 185-370 MBq/kg | Quantitative | 39 | 30 | 0 | 3 | 6 |
| Jung et al. | 2016 | Philips Gemini Dual (Best, The Netherlands) Siemens Biograph TruePoint (Germany) |
5.18 MBq/kg | Quantitative | 110 | 71 | 4 | 13 | 22 |
| Peti et al. | 2014 | GE Medical Systems, Waukesha, WI | NA | Qualitative | 97 | 52 | 6 | 4 | 35 |
| Asagi et al. | 2013 | Toshiba, Otawara, Japan | 3.0 MBq/kg | Quantitative | 17 | 11 | 0 | 0 | 6 |
| Kitajima et al. | 2009 | Siemens AG,Erlangen, Germany | 4.0 MBq/kg | Quantitative | 45 | 22 | 1 | 2 | 20 |